RELATION OF ECHO DOPPLER UTERIN IN THE FIRST TRIMESTER TO FETAL SGA OR IUGR

• Main Author: Bashkim Ismaili
• Format: Article
• Language: English
• Published: Amaltea Medical Publishing House 2019-12-01
• Series: Romanian Journal of Medical Practice
• Subjects: uterine echo doppler; sga
• Online Access: https://revistemedicale.amaltea.ro/Romanian_Journal_of_MEDICAL_PRACTICE/Practica_medicala-2019-Nr.4/RJMP_2019_4_Art-16.pdf

The ECHO Doppler of the uterine artery is used to predict adverse pregnancy outcomes such as. preeclampsia and in the fetal SGA. Objectives. Evaluation of the impact of ECHO Doppler uterine parameters in the first trimester, with the fetal SGA / IUGR. Materials and method. The study is a prospective study conducted at the Special Gynecology Hospital "Mother Teresa", Skopje, and the Clinical-Biochemical Laboratory, Institute of Immunology at the University Clinical Center Skopje R, North Macedonia, and February 2018-September 2019. 698 pregnant women were included in the study. Outcomes. Out of all controlled patients in the period February 2019-June 2010, a total of 698 pregnant women were studied. Increase in ECHO Doppler of uterine arteries. Discussion. Assessment of placental development during pregnancy is one of the most important predictors of fetal development and pre-eclampsia. In modern acupuncture protocols, new diagnostic methods are of particular importance. Conclusion. In our study, ECHO Doppler of uterine arteries resulted in: sensitivity 50%, specificity 50%, PPV 50%, NPV 50%. P = 0.5 R = 0.5. Confirming high reliability of ECHO Doppler uterine arteries in early detection of preeclampsia and its impact on the newborn with SGA / IUGR, further research is needed in relation to these two pregnancy predictors. Recommendations. ECHO Doppler uterine methods have their own difficulties due to the high cost of, and the realization of ECHO Doppler benefits are great and practical. Opportunities for further study are opened, because a new database has been formed in this area of obstetrics from clinically validated and diagnosed patients.